Evidence map›Paper›PMID 25958884›Full record

Observational studyActa obstetricia et gynecologica Scandinavica2015

Antibody response to influenza A(H1N1)pdm09 in vaccinated, serologically infected and unaffected pregnant women and their newborns.

Rikke B Helmig, Rikke D Maimburg, Christian Erikstrup, Henriette S Nielsen, Olav B Petersen, Lars P Nielsen, Lone Hvidman, Jens E Veirum, Tine B Henriksen, Merete Storgaard

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Acta obstetricia et gynecologica Scandinavica, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Rikke B HelmigDepartment of Obstetrics and Gynecology, Aarhus University Hospital, Skejby, Denmark.
Rikke D MaimburgDepartment of Obstetrics and Gynecology, Aarhus University Hospital, Skejby, Denmark.
Christian ErikstrupDepartment of Immunology, Aarhus University Hospital, Skejby, Denmark.
Henriette S NielsenDepartment of Microbiological Diagnostics and Virology, Statens Seruminstitut, Copenhagen, Denmark.
Olav B PetersenDepartment of Obstetrics and Gynecology, Aarhus University Hospital, Skejby, Denmark.
Lars P NielsenDepartment of Microbiological Diagnostics and Virology, Statens Seruminstitut, Copenhagen, Denmark.
Lone HvidmanDepartment of Obstetrics and Gynecology, Aarhus University Hospital, Skejby, Denmark.
Jens E VeirumPediatric Department, Aarhus University Hospital, Skejby, Denmark.
Tine B HenriksenPediatric Department, Aarhus University Hospital, Skejby, Denmark.
Merete StorgaardDepartment of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark.
Aarhus University Hospital · DKAalborg University · DKStatens Serum Institut · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the serological response in pregnant Danish women immunized during the 2009 pandemic by serologic infection or by vaccination with influenza A(H1N1) Pandemrix(®) and describe levels of passively acquired maternal antibody in their offspring.

designObservational cohort study.

settingDepartment of Obstetrics, Aarhus University Hospital, Skejby, Denmark, October to December 2009. POPULATION: Pregnant women and their offspring

methodsSerological analysis of antibodies to influenza A(H1N1)pdm09 by hemagglutination inhibition assay in 197 women and their offspring. Blood samples were collected consecutively at delivery from the mother and the umbilical cord. In a subgroup of 124 of the 197 women, an additional blood sample from gestational weeks 9-12 was available for analysis.

main outcome measuresSeroconversion, geometric mean titer, geometric mean-fold rise and protective antibodies.

results33 of the 124 subgroup women (27%) seroconverted during pregnancy, 79% after vaccination and 17% after serologic infection (p < 0.001). The geometric mean titer after delivery in non-vaccinated, non-serologically infected women was 17.1 (95%CI 15.7-18.6). The geometric mean titer increased significantly after serologic infection with H1N1 [76.5 (95%CI 51.3-113.9), p < 0.001] and after vaccination [589.6 (95%CI 339.3-1024.7), p < 0.001]. The geometric mean-fold rise (mother at delivery/mother early pregnancy) was significantly higher after vaccination [2.23 (1.93-2.54)] than after serologic infection [1.73 (1.59-1.87), p = 0.013]. In newborns of vaccinated mothers, 89.5% had protective antibody levels compared with 15.8% in newborns of serologically infected mothers (p < 0.001).

conclusionsInfluenza vaccination during pregnancy confers passive immunity to the newborn.

Indexed as

Immunity, Maternally-AcquiredInfluenza VaccinesAdultAntibodies, ViralAntibody FormationCohort StudiesDenmarkFemaleHumansInfant, NewbornInfluenza A Virus, H1N1 SubtypeInfluenza, HumanPandemicsPostpartum PeriodPregnancyAntibodies, ViralInfluenza Vaccinespandemrixantibodyimmunityinfluenza A(H1N1)pdm09newbornpregnancyvaccination

Identifiers

PMID25958884
PMCPMC4745092
OpenAlexW1578998747

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.